PharmaCyte Biotech (PMCB) Exchange Rate Effect (2015 - 2026)
PharmaCyte Biotech (PMCB) posted quarterly Exchange Rate Effect of $744.0 for Q2 2026, up 20.58% year-over-year from $617.0 in Q2 2025, and down 71.24% quarter-over-quarter from $2587.0 in Q1 2026.
PharmaCyte Biotech (PMCB) Exchange Rate Effect (2015 - 2026) Analysis & Trends
PharmaCyte Biotech (PMCB) has reported Exchange Rate Effect for 12 consecutive years, with $744.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Exchange Rate Effect rose 20.58% year-over-year to $744.0; the TTM figure through Apr 2026 stood at $3073.0 (up 958.38% YoY), while the FY2026 annual figure was $3073.0, up 958.38% from the prior year.
- Exchange Rate Effect eased to $744.0 in Q2 2026 per PMCB's latest filing, from $2587.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $3544.0 in Q2 2022 and bottomed at -$5276.0 in Q2 2023.
- Historically, Exchange Rate Effect has averaged -$94.72 across 5 years, with a median of $92.0 in 2024.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect jumped 459.87% — and 2023, when it tumbled 1116.19%.
- PharmaCyte Biotech's Exchange Rate Effect stood at -$720.0 in 2022, then tumbled by 120.97% to -$1591.0 in 2023, then surged by 103.83% to $61.0 in 2024, then plunged by 724.59% to -$381.0 in 2025, then soared by 295.28% to $744.0 in 2026.
- Business Quant data shows PMCB's Exchange Rate Effect at $744.0 in Q2 2026, $2587.0 in Q1 2026, and -$381.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.23 Bn | 132.38 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.97 Bn | 78.97 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.88 Bn | 54.74 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 42.20 Bn | 37.11 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.69 Bn | 10.30 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - | - |
| 10 | PharmaCyte Biotech | 4.44 Mn | 4.44 Mn | - | 744.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 744.00 |
| Apr 30, 2026 | 744.00 |
| Jan 31, 2026 | 2,587.00 |
| Jan 31, 2026 | 2,587.00 |
| Oct 31, 2025 | -381.00 |
| Oct 31, 2025 | -381.00 |
| Jul 31, 2025 | 123.00 |
| Jul 31, 2025 | 123.00 |
| Apr 30, 2025 | 617.00 |
| Apr 30, 2025 | 617.00 |
| Jan 31, 2025 | -1,219.00 |
| Jan 31, 2025 | -1,219.00 |
| Oct 31, 2024 | 61.00 |
| Oct 31, 2024 | 61.00 |
| Jul 31, 2024 | 183.00 |
| Jul 31, 2024 | 183.00 |
| Apr 30, 2024 | -438.00 |
| Apr 30, 2024 | -438.00 |
| Jan 31, 2024 | 1,070.00 |
| Jan 31, 2024 | 1,070.00 |